Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ned Sacktor

Showing results (111-120 of 141) with videos related to

Pageof 15
Sort By:
Archives of Neurology|January 11, 2007
An evaluation of neurocognitive status and markers of immune activation as predictors of time to death in advanced HIV infectionJeffrey J Sevigny, Steven M Albert, Michael P McDermott, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 20, 2013
Randomized trial of central nervous system-targeted antiretrovirals for HIV-associated neurocognitive disorderRonald J Ellis, Scott Letendre, Florin Vaida, et al.
AIDS (London, England)|March 15, 2019
Effects of comorbidity burden and age on brain integrity in HIVRowan Saloner, Robert K Heaton, Laura M Campbell, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|December 11, 2020
NIH Workshop on HIV-Associated Comorbidities, Coinfections, and Complications: Summary and Recommendation for Future ResearchSavita Pahwa, Steven Deeks, Shimian Zou, et al.
Brain Imaging and Behavior|January 26, 2011
Subcortical brain atrophy persists even in HAART-regulated HIV diseaseJames T Becker, Joanne Sanders, Sarah K Madsen, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|July 13, 2005
Undetectable cerebrospinal fluid HIV RNA and beta-2 microglobulin do not indicate inactive AIDS dementia complex in highly active antiretroviral therapy-treated patientsLucette A Cysique, Bruce J Brew, Mark Halman, et al.
The Lancet. HIV|June 19, 2019
Correlates of HIV RNA concentrations in cerebrospinal fluid during antiretroviral therapy: a longitudinal cohort studyAlessandro Livelli, Florin Vaida, Ronald J Ellis, et al.
Journal of Neurovirology|June 21, 2019
Heterogeneity in neurocognitive change trajectories among people with HIV starting antiretroviral therapy in Rakai, UgandaLeah H Rubin, Deanna Saylor, Gertrude Nakigozi, et al.
Neurology|February 22, 2019
Impaired insulin sensitivity is associated with worsening cognition in HIV-infected patientsSaja S Khuder, Suming Chen, Scott Letendre, et al.
Journal of Neurovirology|March 29, 2008
Second assessment of NeuroAIDS in AfricaKevin Robertson, Kathy Kopnisky, James Hakim, et al.
Pageof 15

Showing results (111-120 of 141) with videos related to

Sort By:
Pageof 15
Archives of Neurology|January 11, 2007
An evaluation of neurocognitive status and markers of immune activation as predictors of time to death in advanced HIV infectionJeffrey J Sevigny, Steven M Albert, Michael P McDermott, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 20, 2013
Randomized trial of central nervous system-targeted antiretrovirals for HIV-associated neurocognitive disorderRonald J Ellis, Scott Letendre, Florin Vaida, et al.
AIDS (London, England)|March 15, 2019
Effects of comorbidity burden and age on brain integrity in HIVRowan Saloner, Robert K Heaton, Laura M Campbell, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|December 11, 2020
NIH Workshop on HIV-Associated Comorbidities, Coinfections, and Complications: Summary and Recommendation for Future ResearchSavita Pahwa, Steven Deeks, Shimian Zou, et al.
Brain Imaging and Behavior|January 26, 2011
Subcortical brain atrophy persists even in HAART-regulated HIV diseaseJames T Becker, Joanne Sanders, Sarah K Madsen, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|July 13, 2005
Undetectable cerebrospinal fluid HIV RNA and beta-2 microglobulin do not indicate inactive AIDS dementia complex in highly active antiretroviral therapy-treated patientsLucette A Cysique, Bruce J Brew, Mark Halman, et al.
The Lancet. HIV|June 19, 2019
Correlates of HIV RNA concentrations in cerebrospinal fluid during antiretroviral therapy: a longitudinal cohort studyAlessandro Livelli, Florin Vaida, Ronald J Ellis, et al.
Journal of Neurovirology|June 21, 2019
Heterogeneity in neurocognitive change trajectories among people with HIV starting antiretroviral therapy in Rakai, UgandaLeah H Rubin, Deanna Saylor, Gertrude Nakigozi, et al.
Neurology|February 22, 2019
Impaired insulin sensitivity is associated with worsening cognition in HIV-infected patientsSaja S Khuder, Suming Chen, Scott Letendre, et al.
Journal of Neurovirology|March 29, 2008
Second assessment of NeuroAIDS in AfricaKevin Robertson, Kathy Kopnisky, James Hakim, et al.
Pageof 15